Rauch Collaborates in Research to Develop New Treatment Technology for Alzheimer’s Disease

Jennifer Rauch, assistant professor of biochemistry and molecular biology, is collaborating on a two-year, $700,000 National Institutes of Health grant to develop a new technology to treat Alzheimer’s disease, chronic traumatic encephalopathy and other neurodegenerative diseases.

Rauch will be working with grant recipient Novoron Bioscience, a San Diego-based biotechnology company that seeks to develop therapies to reverse central nervous system damage, and Kenneth Kosik of the University of California, Santa Barbara, in whose neurobiology lab Rauch conducted research as a post-doc.